Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001641172-25-011885
Filing Date
2025-05-21
Accepted
2025-05-21 12:09:47
Documents
28

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2763446
2 GRAPHIC image_001.jpg GRAPHIC 11506
3 GRAPHIC chart_001.jpg GRAPHIC 800188
4 GRAPHIC image_002.jpg GRAPHIC 39930
5 GRAPHIC image_003.jpg GRAPHIC 74893
6 GRAPHIC image_004.jpg GRAPHIC 42216
7 GRAPHIC image_005.jpg GRAPHIC 34154
8 GRAPHIC image_006.jpg GRAPHIC 33312
9 GRAPHIC image_007.jpg GRAPHIC 18665
10 GRAPHIC image_008.jpg GRAPHIC 36155
11 GRAPHIC image_009.jpg GRAPHIC 30188
12 GRAPHIC image_010.jpg GRAPHIC 37887
13 GRAPHIC image_011.jpg GRAPHIC 40831
14 GRAPHIC image_012.jpg GRAPHIC 82247
15 GRAPHIC image_013.jpg GRAPHIC 5470
16 GRAPHIC image_014.jpg GRAPHIC 42681
17 GRAPHIC image_015.jpg GRAPHIC 45299
18 GRAPHIC image_016.jpg GRAPHIC 41762
19 GRAPHIC image_017.jpg GRAPHIC 51192
20 GRAPHIC image_018.jpg GRAPHIC 40197
21 GRAPHIC image_019.jpg GRAPHIC 33715
22 GRAPHIC formdrsa_020.jpg GRAPHIC 17878
23 GRAPHIC formdrsa_021.jpg GRAPHIC 245540
24 GRAPHIC formdrsa_022.jpg GRAPHIC 22160
25 GRAPHIC formdrsa_023.jpg GRAPHIC 18077
26 GRAPHIC formdrsa_025.jpg GRAPHIC 31121
27 GRAPHIC vi_001.jpg GRAPHIC 60044
28 GRAPHIC image_020.jpg GRAPHIC 7072
  Complete submission text file 0001641172-25-011885.txt   5445948
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-07416 | Film No.: 25972355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)